When Your Life Sciences Are on the Line: Protecting Your Company’s Most Valuable Asset: Trade Secrets

Morrison Foerster partners Kate Driscoll and Nate Mendell, both former federal prosecutors in the firm’s Investigations + White Collar Defense Group, host the first episode of their new podcast titled When Your Life Sciences Are on the Line, where leading practitioners and thought leaders in the life sciences sector share the insights and advice you need to manage business and legal risk when your life sciences are on the line.

In this episode, Kate and Nate spoke with Jim Krenn, a partner in Morrison Foerster’s Emerging Companies + Venture Capital and Mergers + Acquisitions Practice Groups, about how emerging and established life sciences companies can build and preserve value by protecting their most valuable asset: their trade secrets. Listen in for strategies for emerging and established companies looking to position themselves for growth, for acquisition, and for going public. What are the right steps to take now that technology allows for more sophisticated and less detectable trade secrets theft? What is the value proposition of implementing protections, and what do investors expect now that cyberattacks are prevalent? Topics of discussion also include strategies for scaling compliance programs and data security practices throughout a company’s lifecycle, and preferred strategies for testing existing policies and systems to identify vulnerabilities.